These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34217145)

  • 1. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
    Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
    Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity correlates with the immunosuppressive ILC2s-MDSCs axis in advanced breast cancer.
    Liu W; Li B; Liu D; Zhao B; Sun G; Ding J
    Immun Inflamm Dis; 2024 Mar; 12(3):e1196. PubMed ID: 38501542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
    Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
    Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis.
    Trabanelli S; Chevalier MF; Martinez-Usatorre A; Gomez-Cadena A; Salomé B; Lecciso M; Salvestrini V; Verdeil G; Racle J; Papayannidis C; Morita H; Pizzitola I; Grandclément C; Bohner P; Bruni E; Girotra M; Pallavi R; Falvo P; Leibundgut EO; Baerlocher GM; Carlo-Stella C; Taurino D; Santoro A; Spinelli O; Rambaldi A; Giarin E; Basso G; Tresoldi C; Ciceri F; Gfeller D; Akdis CA; Mazzarella L; Minucci S; Pelicci PG; Marcenaro E; McKenzie ANJ; Vanhecke D; Coukos G; Mavilio D; Curti A; Derré L; Jandus C
    Nat Commun; 2017 Sep; 8(1):593. PubMed ID: 28928446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
    Symowski C; Voehringer D
    Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
    Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
    Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of OX40/OX40L in ILC2-mediated activation of CD4
    Wu J; Cui Y; Zhu W; Bai S; Zhao N; Liu B
    Int Immunopharmacol; 2019 Nov; 76():105784. PubMed ID: 31470268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.
    Drake LY; Iijima K; Kita H
    Allergy; 2014 Oct; 69(10):1300-7. PubMed ID: 24939388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.
    Dawod B; Liu J; Gebremeskel S; Yan C; Sappong A; Johnston B; Hoskin DW; Marshall JS; Wang J
    Sci Rep; 2020 Aug; 10(1):13343. PubMed ID: 32770025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Metastatic Stage-Dependent ILC2 Activation Induces Differential Functions of MDSCs through IL-13/IL-13Rα1 Signaling during the Progression of Breast Cancer Lung Metastasis.
    Ito A; Akama Y; Satoh-Takayama N; Saito K; Kato T; Kawamoto E; Gaowa A; Park EJ; Takao M; Shimaoka M
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase Cθ controls type 2 innate lymphoid cell and T
    Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
    J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.
    Stier MT; Bloodworth MH; Toki S; Newcomb DC; Goleniewska K; Boyd KL; Quitalig M; Hotard AL; Moore ML; Hartert TV; Zhou B; McKenzie AN; Peebles RS
    J Allergy Clin Immunol; 2016 Sep; 138(3):814-824.e11. PubMed ID: 27156176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis.
    Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q
    Front Immunol; 2021; 12():670676. PubMed ID: 33995408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
    Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
    Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
    [No Abstract]   [Full Text] [Related]  

  • 17. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer.
    Kumar S; Wilkes DW; Samuel N; Blanco MA; Nayak A; Alicea-Torres K; Gluck C; Sinha S; Gabrilovich D; Chakrabarti R
    J Clin Invest; 2018 Nov; 128(11):5095-5109. PubMed ID: 30295647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS
    J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for
    Jou E; Rodriguez-Rodriguez N; Ferreira AF; Jolin HE; Clark PA; Sawmynaden K; Ko M; Murphy JE; Mannion J; Ward C; Matthews DJ; Buczacki SJA; McKenzie ANJ
    Sci Immunol; 2022 Jun; 7(72):eabn0175. PubMed ID: 35658010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
    Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
    J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.